Follow the Integrated Diagnostics Holding plc stock price and the full directors' dealings record of the company, a listed issuer based in United Kingdom. Shares are quoted on the UK market, under the authority of RNS (LSE). Market capitalisation: €311m. The latest transaction was reported on 23 June 2026 (Purchase). Among the most active insiders: Hena Holdings Ltd. The full history is accessible without an account.
8
Insider Decl.
n/a
Thresholds
€1m
8 ops.
Buy Volume
n/a
n/a
Sell Volume
15Σ signal
Buys €1mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 378 of 29,063 companies
86.2
score / 100
Value
100
Quality
73
FCF yld·
Earn yld·
EV/EBITDA0.7x
ROE·
Gross mgn43%
Net mgn16%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
150,000 shares@ £0.382100.0% of flowLondon Stock ExchangeISINISIN JE00BLKGSR75RNS:4802749
8 of 8 declarations
Acerca de Integrated Diagnostics Holding plc
Integrated Diagnostics Holding plc es una empresa especializada en servicios de diagnóstico médico en Egipto y otros países de la región. Ofrece una gama de pruebas de laboratorio y servicios de salud para pacientes y profesionales de la salud.